Navigation Links
AES in Medical News

96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy

...s. 14 percent), cough (11 percent vs. 9 percent) and herpes simplex (10 percent vs. 10 percent). The incidence of nervous system and psychiatric aes was comparable between the INTELENCE and placebo arms. Nineteen percent of patients in the INTELENCE arm experienced nervous system disorders and 20 p...

InfoWallet, A New Innovative Secure, Portable, Multi-Platform, Personal Life Manager Software Is Now Available

...llet supports the most popular and robust world class strong-encryption schemes for absolutely bullet-proof information security. InfoWallet supports: aes encryption at 128, 192, and 256 bits, Blowfish at 128, and 448 bits, TripleDES 192 bit InfoWallet tracks visits to each doctor and all resulting p...

Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis

...,152 to 31,431 umol in the four treatment groups There were no SAEs or aes leading to withdrawal during the study. The most common system organ class ...ions" (32 events in 18 subjects), and of these the most frequent individual aes were increased body temperature, which was reported in 10 subjects (all fro...

Landmark Rh Immune Globulin Celebrates 40 Years of Saving Babies' Lives

...he patient. ADVERSE REACTIONS Adverse events (AE) after administration of RhoGAM and MICRhoGAM are rare. The most frequently reported aes are anti-D formation and injection site reactions, such as swelling, induration, redness and mild pain or warmth. Possible systemic reactions are skin...

GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer

...abine refractory group (n=79).(5,6) The most common adverse events (AEs) seen with ofatumumab were related to infusion reactions and infections. aes seen in at least 10 percent of patients included fever, cough, diarrhea, rash, low white blood cell counts, fatigue, pneumonia, anemia, shortness of b...

InterMune Reports Results from Triple Combination Study of ITMN-191

...ents (SAE) or Grade 4 adverse events (AEs) during treatment with ITMN-191. aes reported during study treatment (ITMN-191 or placebo) were predominantly mi...e (SOC) and none led to treatment discontinuation. Only four Grade 3 aes were reported during study treatment, two of which (sciatica and back pain)...

Berkshire Medical Center Selects Desktop Alert for Mass Notification Solutions

...digital signage devices. Desktop Alert securely extends alerting to personal computers outside the network by the utilization of Protexx 256 Bit aes digital encryption certificates which protects data in motion thus providing the ability to instantly allow secure external connectivity for remote em...

Berkshire Medical Center Selects Desktop Alert for Mass Notification Solutions

...digital signage devices. Desktop Alert securely extends alerting to personal computers outside the network by the utilization of Protexx 256 Bit aes digital encryption certificates which protects data in motion thus providing the ability to instantly allow secure external connectivity for remote em...

New Research Reports on Interventions that May Alter the Course of Epilepsy Diagnosis and Management

...epsy management. Three studies highlighted at the aes annual meeting address this goal from different va...and treat epilepsy," said Dennis D. Spencer, M.D., aes President, Harvey and Kate Cushing Professor and C...sures in Epilepsy Monitoring Units A new aes survey of physicians and nurses provided the basis...

New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes

...nces of overall adverse experiences (AEs), serious aes and aes leading to discontinuation were 46 and 53 percent,...and 13 percent and 5 and 3 percent. Clinical aes of hypoglycemia and selected gastrointestinal (GI)...

More>>

AES in Medical Technology

Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)

...and -5.6 plus or minus 6.4 points ( 240 U group) . aes occurred in 34.8% of patients of the placebo group...% of the 120 U group and 46.0% of the 240 U group. aes reported most frequently were dysphagia (4.3% vs 8...) and -5.4 plus or minus 5.5 points (240 U group). aes occurred in 53.6% of patients of the placebo group...

Micromet Presents Update on Blinatumomab's Response Rate and Duration in a Phase 1 Study in Non-Hodgkin's Lymphoma Patients

...s (AEs) included lymphopenia, pyrexia, and leukopenia. The vast majority of aes occurred early during treatment and improved or resolved during treatment. Permanent treatment discontinuation due to aes resulted from infections, liver enzyme increases and fully reversible centr...

New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar

...ntly among the 3 arms. Overall incidence and severity of adverse events (AEs) were comparable among the 3 treatment arms. The most frequently reported aes included upper respiratory tract infections (5.2%), peripheral edema (4.1%), pain in extremity (3.8%), nasopharyngitis (3.5%), sinusitis (3.2%), and b...

Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US

... were also demonstrated. DCCR was generally well tolerated, and most of the aes were mild to moderate, resolving without sequelae. There were no SAEs and the discontinuation rate due to aes was in line with historic lipid-lowering trials. Separately, the comp...

Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results

... The withdrawal rates due to adverse events (AEs) were similar with BENICAR to placebo: BENICAR (2.4% vs 2.7%); The incidence of aes with BENICAR was similar to placebo-- The only AE that occurred in >1% of patients treated with BENICAR(R) and more frequently than placebo was diz...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

...s (AEs). In this trial, occurrence of drug-related aes included: dizziness (3.4 percent), hypotension (2....ENICAR HCT (2.0% vs 2.0%) The incidence of aes with BENICAR and BENICAR HCT was similar to placeb...tly than placebo was dizziness (3% vs 1%) -- aes reported in >2% of patients taking BENICAR HCT(...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure

...atient, 2 AZOR patients) of the 185 patients discontinuing treatment because of drug-related adverse events. In this trial, occurrence of drug-related aes included: peripheral edema (2.2 percent) and dizziness (1.1 percent). High blood pressure can cause permanent changes to blood vessels and the h...

Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients

...0.9 +/- 11.7 points (240 U group) (p < 0.001). aes occurred in 41.9% of the placebo group, 56.4% of the 120 U group and 55.6% of the 240 U group. aes reported most frequently for each group respective...t-to-treat (ITT) population using an ANCOVA model. aes were collected via direct questioning. Resu...

InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)

...ents (SAE) or Grade 4 adverse events (AEs) during treatment with ITMN-191. aes reported during study treatment (ITMN-191 or placebo) were predominantly mi...e (SOC) and none led to treatment discontinuation. Only four Grade 3 aes were reported during study treatment, two of which (sciatica and back pain)...

Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders

...YL and HPN-100 were administered TID with meals. Twenty-one adverse events (AEs) occurred in seven subjects during BUPHENYL treatment and fifteen aes occurred in five subjects with HPN-100. There were two SAEs related to hyperammonemia; both occurred during 100% BUPHENYL treatment. No SAEs occurre...
AES in Biological Technology

InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights

... well tolerated in the study. There were no serious adverse events or Grade 4 adverse events (AEs) during treatment with ITMN-191. aes reported during study treatment (ITMN-191 or placebo) were predominantly mild to moderate in severity, typically consistent with the...

InterMune Announces Issuance of U.S. Patent for ITMN-191

...generally safe and well tolerated in the study. There were no serious adverse events or Grade 4 adverse events (AEs) during treatment with ITMN-191. aes reported during study treatment (ITMN-191 or placebo) were predominantly mild to moderate in severity, typically consistent with the AE profile of sta...

Multiple Vimpat(R) (lacosamide) Studies Presented at American Epilepsy Society Annual Meeting

...g/day Vimpat(R) groups. Summary of Vimpat(R) Data Presented at 2008 aes Annual Meeting Early Onset of Efficacy in the Initial Weeks of Trea...r troublesome TEAEs such as somnolence and cognitive and psychiatric aes appeared low: -- The incidence of somnolence was 7 percent for the...

Beyond Seizure Control in the Treatment of Epilepsy With New Anti-Epileptic Drug, Zebinix(TM)

... seizures by over one third during the 12 week maintenance period of the studies.(5),(6),(7),(8) In addition, new data presented for the first time at aes demonstrates that the reduction in seizure frequency was sustained over a one-year open-label treatment period. This sustained reduction over one year...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

...oup (14%). In the PRECiSE 2 trial, the most common aes in the CIMZIA(R) group were headache (7%), nasopha...yngitis (6%) and cough (6%). For the placebo group aes included headache (7%), nasopharyngitis (4%) and c...1%) compared to in the placebo group (5%). Serious aes were broadly similar in both groups (6% CIMZIA(R) ...

Phase I Safety and Tolerability Study With EVT 302 Successfully Completed

...related were transient and mostly of mild intensity; only very few moderate aes were reported. No severe or serious aes occurred. No clinically relevant changes in lab values of haematology or ...

New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms of Major Depressive Disorder Versus Placebo

...similar to placebo. In the two studies, the rates of discontinuation due to aes for placebo and PRISTIQ 100 mg/day were three percent and seven percent, re....0). Safety Analysis In the U.S. study, rates of discontinuation due to aes for the placebo, desvenlafaxine 50 mg/day and desvenlafaxine 100 mg/day gro...

Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer

...Grade 2; the increases were clinically asymptomatic and not associated with aes or dose reduction or delay. One patient who experienced an event of asympto...Tc values (Grade 2) and was withdrawn from the study. A total of 16 serious aes were reported in 8 patients. 5 events in 4 patients were considered possibl...

PKWare launches new enterprise product line, adds new features to PKZip

...easy-to-use toolbar and integration with Outlook and Notes. Security of files can be enabled using password-based strong encryption, with support for aes and 3DES. These two new releases represent a repositioning and re-branding for PKWare. The PKZip products represent the companies enhanced data com...

Cool tools for hot markets

... getting beefier for wireless LANs. The 802.11i spec received approval from the IEEE. It adds the Advanced Encryption Standard to the 802.11 standard. aes will answer some of the criticism of Wi-Fi Protected Access (WPA) . . . The presumptive nominee of the Democratic Party is putting the Bush administra...
AES in Biological Dictionary

Zygotene

...... ( D) Zygotene . ... Examples of spreads of zygotene SCs with early nodules from each of the six ... Frequency of ENs associated with SCs and aes during zygotene for six plant species ... At the zygotene , pachytene and diplotene stages, oocytes with fragmented axial ... The dura...
Other Tags
(Date:8/27/2015)... Memphis,TN (PRWEB) , ... August 28, 2015 , ... ... hardships of youth aging out of foster care through “The Language of Flowers,” ... in supporting Youth Villages’ work, particularly the organization’s YVLifeSet program, was piqued by ...
(Date:8/27/2015)... ... 27, 2015 , ... Keck Graduate Institute (KGI), School of Pharmacy celebrated its ... a formal ceremony recognizing them as members of the 2nd class of the KGI ... Symbolizing dedication to clinical service and patient care, the White Coat Ceremony is held ...
(Date:8/27/2015)... , ... August 27, 2015 , ... In the addiction ... leaving weeks or months later, relapsing and returning again, all at great cost to ... while in sober living homes or soon after leaving facilities who claim to have ...
(Date:8/27/2015)... ... August 27, 2015 , ... According to an ... on Abdominal Wall Hernia Surgery involved many conversations between hernia experts surrounding the search ... the article notes that many different experts have different ideas about which is the ...
(Date:8/27/2015)... ... ... Thriveology Founders, Dr. Carly Letzt Carney and Dr. Mark Carney announced today that ... on Saturday, August 29, 2015 at the Marriott DTC, 4900 S. Syracuse Street, Denver, ... will present a two part seminar entitled, “How to Thrive as You Age & ...
Breaking Medicine News(10 mins):Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 3Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 3Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 4Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 2Health News:National Screenings of Documentary Indicate Burgeoning Questions about the Effectiveness of Addiction Treatment Facilities 3Health News:Recent Article on Hernia Mesh Developments Highlights Viable Options, But Shows a Need for Further Research, notes Dr. Shirin Towfigh 2Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2
(Date:8/5/2015)... , August 5, 2015 ... titled "Facial Recognition Market - Global Industry Analysis, Size, ... global market for facial recognition is forecast to reach ... by increased demand for surveillance systems by civil and ... number of crimes and terrorist activities across the globe ...
(Date:8/4/2015)... 4, 2015  AMRI (NASDAQ: AMRI ) today reported financial ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 ... including a $0.05 decrease in EPS from royalties in the current ... "We are very pleased to present another strong ...
(Date:7/31/2015)... SHENZHEN, China , 31 de julio de 2015 ... sobre Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 ... . La conferencia celebra su décimo ... se ha convertido en una de las reuniones anuales ... ,ómicas, y es una de las conferencias científicas más ...
Breaking Biology News(10 mins):Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
Other Contents